| Nome do produto |
Mubritinib |
| Sinônimos |
1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole; 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole |
| Fórmula molecular |
C25H23F3N4O2 |
| Peso Molecular |
468.4709 |
| InChI |
InChI=1/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+ |
| CAS Registry Number |
366017-09-6 |
| Estrutura Molecular |
|
| Densidade |
1.25g/cm3 |
| Ponto de ebulição |
620.9°C at 760 mmHg |
| índice de refração |
1.577 |
| O ponto de inflamação |
329.3°C |
|
